Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information for Common Stock
Our common stock trades on the Nasdaq Global Select Market under the symbol “ICUI.”
Stockholders
As of January 31, 2026, we had 31 stockholders of record. This does not include persons whose shares are held in nominee or “street name” accounts through brokers.
Securities authorized for issuance under equity compensation plans are discussed in Part III, Item 12 of this Annual Report on Form 10-K.
Dividends
We have never paid dividends and do not anticipate paying dividends in the foreseeable future as the Board of Directors intends to retain future earnings for use in our business to pay down our long-term debt or to purchase our shares. Any future determination as to payment of dividends or purchase of our shares will depend upon our financial condition, results of operations and such other factors as the Board of Directors deems relevant.
Issuer Purchases of Equity Securities
The following is a summary of our stock repurchasing activity during the fourth quarter of 2025:
Period Shares
purchased Average
price paid
per share Shares
purchased
as part of a
publicly
announced
program Approximate
dollar value that
may yet be
purchased
under the
program (1)
10/01/2025 - 10/31/2025 — $ — — $ 100,000,000
11/01/2025 - 11/30/2025 — $ — — $ 100,000,000
12/01/2025 - 12/31/2025 — $ — — $ 100,000,000
Fourth quarter 2025 total — $ — — $ 100,000,000
____________________________
(1) Our common stock purchase plan, which authorized the repurchase of up to $100.0 million of our common stock, was authorized by our Board of Directors and publicly announced in August 2019. This plan has no expiration date. We are not obligated to make any purchases under our stock purchase program. Subject to applicable state and federal corporate and securities laws, purchases under a stock purchase program may be made at such times and in such amounts as we deem appropriate, depending on a variety of factors, including our financial position, earnings, share price, capital requirements, other investment opportunities (including mergers and acquisitions and related financings), market conditions and other factors. Purchases made under our stock purchase program can be discontinued at any time we determine additional purchases are not warranted.
40
COMPARISON OF CUMULATIVE TOTAL RETURN FROM DECEMBER 31, 2020 TO DECEMBER 31, 2025 OF ICU MEDICAL, INC., NASDAQ AND NASDAQ MEDICAL SUPPLIES INDEX
The following graph shows the total stockholder return on our common stock based on the market price of the common stock from December 31, 2020 to December 31, 2025 and the total returns of the NASDAQ U.S. Index and NASDAQ Medical Supplies Index for the same period.
12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
ICU Medical, Inc. 100.00 110.65 73.42 46.50 72.34 66.52
Nasdaq U.S. Index 100.00 125.89 101.05 127.76 159.03 186.96
Nasdaq Medical Supplies Index 100.00 120.03 78.70 83.26 75.71 67.95
Assumes $100 invested on December 31, 2020 in ICU Medical Inc.’s common stock, the NASDAQ U.S. Index and the NASDAQ Medical Supplies Index and that all dividends, if any, were reinvested.
ITEM 6. RESERVED
Not applicable.